BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CRMT
America's Car-Mart, Inc.
There isn't enough reported data to score CRMT yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CRMT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CRMT PE Valuation
CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CRMT on the outlook, with more favorable revenue expectations.
CRMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRMT to return to profit, with revenue declining.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CRMT on earnings quality, reporting a profit while its opponent remains loss making.
CRMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q3 2026 | -$24.38 | -1462% |
| Q2 2026 | -$16.79 | -821% |
| Q1 2026 | -$11.15 | -1312% |
| Q4 2025 | -$1.53 | -$0.74 |
| Q3 2025 | $1.79 | +$7.49 |
| Q2 2025 | $2.33 | +$7.25 |
| Q1 2025 | $0.92 | +$5.60 |
| Q4 2024 | -$0.79 | +$2.32 |
CRMT has swung to a loss: it lost $24.38 per share over the past year, after a profit the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CRMT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over CRMT on profitability, with a higher operating margin.
CRMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $145.8M | -57% |
| Q2 2026 | $302.8M | -18% |
| Q1 2026 | $286.8M | -12% |
| Q4 2025 | $350.2M | +0.8% |
| Q3 2025 | $341.3M | -1.9% |
| Q2 2025 | $370.2M | +1.5% |
| Q1 2025 | $325.7M | +8.7% |
| Q4 2024 | $347.3M | -4% |
CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | -45 points |
| Q2 2026 | -12% | -15 points |
| Q1 2026 | -13% | -14 points |
| Q4 2025 | -7.8% | -9.9 points |
| Q3 2025 | -2.2% | -1.8 points |
| Q2 2025 | 3.4% | +3.2 points |
| Q1 2025 | 1.4% | +4.8 points |
| Q4 2024 | 2% | +12 points |
CRMT's operating margin was −47% last quarter, down 45 points from the same quarter a year ago, near the bottom of its range since 2019.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CRMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80M | +$86.4M |
| Q2 2026 | $67.4M | +266% |
| Q1 2026 | -$6.2M | +$25.3M |
| Q4 2025 | $8.3M | +$31.9M |
| Q3 2025 | -$6.4M | +$9.6M |
| Q2 2025 | $18.4M | +$30.4M |
| Q1 2025 | -$31.5M | -408% |
| Q4 2024 | -$23.6M | +$7.9M |
CRMT has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CRMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +40.2K shares |
| 1 year | +0.7% | +55.5K shares |
| 3 years | +26% | +1.7M shares |
| 5 years | +19% | +1.3M shares |
| Available history | +20% | +1.4M shares |
CRMT has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25,000 |
| Q2 2026 | $2,000 |
| Q1 2026 | $23,000 |
| Q4 2025 | $205,000 |
| Q3 2025 | $71,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $20,000 |
| Q4 2024 | $388,000 |
CRMT spent $255,000 buying back its own shares over the past year, down 47% from the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
CRMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2023 | -0.3x | Net Cash |
| Q2 2023 | 5.1x | High |
| Q4 2022 | 3.5x | Elevated |
| Q3 2022 | 1.7x | Healthy |
CRMT has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CRMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 18.7 | Oversold |
CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CRMT PE vs Consumer Cyclical Sector
| Metric | CRMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CRMT has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CRMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.09 | 15% below |
| 20 week MA | $2.09 | 56% below |
| 50 week MA | $11.0 | 92% below |
| 100 week MA | $27.0 | 97% below |
| 200 week MA | $49.6 | 98% below |
CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over CRMT on returns for 2026, with the stronger performance.
CRMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.6 | $110.0 | +1.3% |
| 2021 | $110.0 | $102.8 | -6.5% |
| 2022 | $102.8 | $72.1 | -30% |
| 2023 | $72.1 | $75.8 | +5.1% |
| 2024 | $75.8 | $52.3 | -31% |
| 2025 | $52.3 | $25.9 | -51% |
| 2026 YTD | $25.9 | $0.93 | -96% |
CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.